Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
Kirsten L. Viola, Maíra A. Bicca, Adrian M. Bebenek, et al.
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 20

Showing 20 citing articles:

Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Golnaz Yadollahikhales, Julio C. Rojas
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 914-931
Open Access | Times Cited: 86
Behaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model
Mafalda Soares Pádua, José Luis Guil‐Guerrero, Paula A. Lopes
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6766-6766
Open Access | Times Cited: 15
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Sudipta Senapati, Kuldeep Tripathi, Khadeja Awad, et al.
Small (2024) Vol. 20, Iss. 31
Open Access | Times Cited: 14
Anti-amyloid Antibody Therapies for Alzheimer’s Disease
Kyung Won Park
Nuclear Medicine and Molecular Imaging (2024) Vol. 58, Iss. 4, pp. 227-236
Closed Access | Times Cited: 7
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Xiangyuan Meng, Qi Song, Zinan Liu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 7
Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2023) Vol. 480, Iss. 15, pp. 1217-1240
Open Access | Times Cited: 15
Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases
Elizabeth A. Johnson, Raghad Nowar, Kirsten L. Viola, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
A turn for the worse: Aβ β-hairpins in Alzheimer’s disease
Sarah M. Ruttenberg, James S. Nowick
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117715-117715
Open Access | Times Cited: 3
Targeting soluble amyloid-beta oligomers with a novel nanobody
Justin R. Haynes, Clayton A. Whitmore, William J. Behof, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics
Sharif Arar, Md. Anzarul Haque, Rakez Kayed
Proteins Structure Function and Bioinformatics (2023)
Open Access | Times Cited: 5
M13 phage grafted with peptide motifs as a tool to detect amyloid-β oligomers in brain tissue
Ivone M. Martins, Alexandre Lima, Wim de Graaff, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Targeting Soluble Amyloid-Beta Oligomers With a Novel Nanobody
Justin R. Haynes, Clayton A. Whitmore, William J. Behof, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies
Szymon Kotarba, Marta Kozłowska, Małgorzata Scios, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10797-10797
Open Access | Times Cited: 1
Natural IgG antibodies to β amyloid are decreased in patients with Parkinson’s disease
Roberto Paganelli, Alessia Paganelli, Graham Pawelec, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer’s disease mouse models
Jang Woo Park, Yunan Tian, Sang‐Tae Kim, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Gene deletion of Pregnancy-associated Plasma Protein-A (PAPP-A) improves pathology and cognition in an Alzheimer's disease mouse model
Laurie K. Bale, Sally A. West, Naomi M. Gades, et al.
Experimental Neurology (2024) Vol. 382, pp. 114976-114976
Closed Access
Amyloid β Proteoforms Elucidated by Quantitative LC/MS in the 5xFAD Mouse Model of Alzheimer’s Disease
Soumya Kandi, Erika N. Cline, Brianna M. Rivera, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 11, pp. 3475-3488
Closed Access | Times Cited: 1
Radiolabeled imaging agents for Alzheimer's disease
Jiajun Wu, Kexin Li, Jie Yang, et al.
iRadiology (2023) Vol. 2, Iss. 1, pp. 80-95
Open Access | Times Cited: 1
Dietary Supplemented Anthocyanin Reduced Serum Amyloid Beta Oligomers and Improved Cognitive Dysfunction Scores in Elderly Dogs
Mi-Jin Lee, Miey Park, Hae‐Jeung Lee
Applied Sciences (2022) Vol. 12, Iss. 23, pp. 12130-12130
Open Access | Times Cited: 2
Elucidation of Amyloid-Beta’s Gambit in Oligomerization: Truncated Aβ fragments of residues Aβ1-23, Aβ1-24 and Aβ1-25 rapidly seed to form SDS-stable, LMW Aβ oligomers that impair synaptic plasticity
Beatriz Gutiérrez‐Gil, Jamie Rose, Davide Demurtas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1

Scroll to top